Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History $3.30 +0.04 (+1.23%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Citius Pharmaceuticals Stock Price Performance 5 Day Performance-5.44%1 Month Performance+27.41%3 Month Performance-66.24%6 Month Performance-84.03%Year-To-Date Performance-17.50%1 Year Performance-82.40% Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CTXR Stock Chart for Saturday, January, 18, 2025 CTXR Chart by TradingView Citius Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$3.26$3.30+1.23%$3.31$3.1378,395 shs$25.50 million01/16/2025$3.40$3.26-4.12%$3.44$3.13106,853 shs$25.20 million01/15/2025$3.56$3.40-4.49%$3.69$3.3173,253 shs$24.58 million01/14/2025$3.49$3.56+2.01%$3.73$3.38109,306 shs$25.74 million01/13/2025$3.63$3.49-3.86%$3.75$3.43118,399 shs$26.97 million01/10/2025$3.71$3.63-2.16%$3.82$3.5585,165 shs$28.05 million01/09/2025$3.71$3.71$3.99$3.61193,630 shs$28.67 million01/08/2025$4.37$3.71-15.10%$3.99$3.61193,630 shs$28.67 million01/07/2025$3.91$4.37+11.76%$4.43$3.92180,442 shs$33.77 million01/06/2025$3.98$3.91-1.76%$4.10$3.86102,120 shs$30.21 million Get the Latest News and Ratings for CTXR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/03/2025$3.88$3.98+2.58%$4.14$3.75156,174 shs$30.75 million01/02/2025$4.00$3.88-3.00%$4.51$3.70233,674 shs$29.98 million01/01/2025$4.00$4.00$5.95$3.971.10 million shs$30.91 million12/31/2024$3.91$4.00+2.30%$5.95$3.971.10 million shs$28.92 million12/30/2024$3.68$3.91+6.25%$4.40$3.40374,128 shs$28.27 million12/27/2024$3.31$3.68+11.18%$3.73$3.24184,700 shs$26.60 million12/26/2024$3.13$3.31+5.75%$3.35$3.05103,030 shs$23.93 million12/25/2024$3.13$3.13$3.15$2.8971,299 shs$22.63 million12/24/2024$2.91$3.13+7.56%$3.15$2.8971,299 shs$22.63 million12/23/2024$2.60$2.91+11.92%$3.04$2.59132,038 shs$21.04 million12/20/2024$2.57$2.60+1.17%$2.74$2.48100,002 shs$18.80 million12/19/2024$2.59$2.57-0.77%$2.68$2.4755,055 shs$18.58 million12/18/2024$2.73$2.59-5.13%$2.79$2.44139,545 shs$18.72 million12/17/2024$2.58$2.73+5.81%$2.85$2.44130,509 shs$19.74 million Related Companies TARA Stock Chart INZY Stock Chart MGX Stock Chart IGMS Stock Chart MIST Stock Chart OSTX Stock Chart ENTA Stock Chart DBVT Stock Chart CRDL Stock Chart ELUT Stock Chart Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTXR) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTXR Stock Alerts